Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Erratum to: Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB<sub>1.</sub>
Koller VJ, Zlabinger GJ, Auwärter V, Fuchs S, Knasmueller S.
Arch Toxicol. 2013 May 17. [Epub ahead of print] No abstract available.
Related citations
Antagonists for the orphan G protein-coupled receptor GPR55 based on a coumarin scaffold.
Rempel V, Volz N, Gläser F, Nieger M, Bräse S, Müller CE.
J Med Chem. 2013 May 16. [Epub ahead of print]
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain.
Uhelski ML, Cain DM, Harding-Rose C, Simone DA.
Neuroscience. 2013 May 11. doi:pii: S0306-4522(13)00414-4. 10.1016/j.neuroscience.2013.05.003. [Epub ahead of print]
Cervical screening, high-grade squamous lesions, and cervical cancer in illicit drug users.
Kricker A, Burns L, Goumas C, Armstrong BK.
Cancer Causes Control. 2013 May 12. [Epub ahead of print]
Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
Khasabova IA, Holman M, Morse T, Burlakova N, Coicou L, Harding-Rose C, Simone DA, Seybold VS.
Neurobiol Dis. 2013 May 2. doi:pii: S0969-9961(13)00132-0. 10.1016/j.nbd.2013.04.018. [Epub ahead of print]
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
Tanasescu R, Constantinescu CS.
Expert Opin Drug Metab Toxicol. 2013 Apr 27. [Epub ahead of print]
Cytotoxic effect of Efavirenz is selective against cancer cells and associated with the cannabinoid system.
Hecht M, Harrer T, Büttner M, Schwegler M, Erber S, Fietkau R, Distel LV.
AIDS. 2013 Apr 26. [Epub ahead of print]
The endocannabinoid signaling system in cancer.
Pisanti S, Picardi P, D'Alessandro A, Laezza C, Bifulco M.
Trends Pharmacol Sci. 2013 May;34(5):273-82. doi: 10.1016/j.tips.2013.03.003. Epub 2013 Apr 17.
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck.
Klein Nulent TJ, Van Diest PJ, van der Groep P, Leusink FK, Kruitwagen CL, Koole R, Van Cann EM.
Br J Oral Maxillofac Surg. 2013 Apr 16. doi:pii: S0266-4356(13)00104-6. 10.1016/j.bjoms.2013.03.015. [Epub ahead of print]
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
Salazar M, Lorente M, García-Taboada E, Hernández-Tiedra S, Davila D, Francis SE, Guzmán M, Kiss-Toth E, Velasco G.
Biochim Biophys Acta. 2013 Apr 6. doi:pii: S1388-1981(13)00085-1. 10.1016/j.bbalip.2013.03.014. [Epub ahead of print]
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination.
Wu CS, Chen H, Sun H, Zhu J, Jew CP, Wager-Miller J, Straiker A, Spencer C, Bradshaw H, Mackie K, Lu HC.
PLoS One. 2013;8(4):e60314. doi: 10.1371/journal.pone.0060314. Epub 2013 Apr 2.
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6 glioma cells assessed by the MTT cell viability assay: implications for the methodology of the MTT tests.
Bilmin K, Kopczyńska B, Grieb P.
Folia Neuropathol. 2013;51(1):44-50.
Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.
Gustafsson SB, Wallenius A, Zackrisson H, Popova D, Plym Forshell L, Jacobsson SO.
Arch Toxicol. 2013 Apr 4. [Epub ahead of print]
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Vincenzi F, Targa M, Corciulo C, Tabrizi MA, Merighi S, Gessi S, Saponaro G, Baraldi PG, Borea PA, Varani K.
Pain. 2013 Jun;154(6):864-73. doi: 10.1016/j.pain.2013.02.007. Epub 2013 Feb 26.
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB<sub>1.</sub>
Arch Toxicol. 2013 Mar 15. [Epub ahead of print]
Development and preliminary validation of a plate-based CB1/CB2 receptor functional assay.
Dossou KS, Devkota KP, Kavanagh PV, Beutler JA, Egan JM, Moaddel R.
Anal Biochem. 2013 Jun 15;437(2):138-43. doi: 10.1016/j.ab.2013.02.025. Epub 2013 Mar 7.
Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors.
Madadi NR, Penthala NR, Brents LK, Ford BM, Prather PL, Crooks PA.
Bioorg Med Chem Lett. 2013 Apr 1;23(7):2019-21. doi: 10.1016/j.bmcl.2013.02.025. Epub 2013 Feb 14.
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.
Cooper ME, Regnell SE.
Br J Clin Pharmacol. 2013 Mar 4. doi: 10.1111/bcp.12102. [Epub ahead of print]
Cannabinoids may be therapeutic in breast cancer.
Behrend SW.
Oncol Nurs Forum. 2013 Mar;40(2):191-2. doi: 10.1188/13.ONF.191-192. No abstract available.
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer.
Jung CK, Kang WK, Park JM, Ahn HJ, Kim SW, Taek Oh S, Choi KY.
Oncol Lett. 2013 Mar;5(3):870-876. Epub 2012 Dec 18.
Filters: Manage Filters